-

Hims & Hers Launches New Android Apps

Launch on Android follows successful rollout in Q1 across iOS App Store
iOS apps have driven 3x greater customer engagement since launch1

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced that both the Hims and Hers mobile apps are now available on Android via the Google Play Store. This follows the successful rollout of the apps on Apple's iOS earlier this year, and means that the Hims and Hers apps are now accessible to anyone with an Apple or Android device.

Hims & Hers developed its mobile platform to provide consumers with an even more accessible, holistic, supportive, and proactive approach to their health and wellness. Early results show that through the apps, consumers are engaging with the brand 3x more frequently than historically through the website.1

The Hims and Hers apps allow users to manage their subscriptions, track shipping, and shop the entire Hims & Hers collection of non-prescription products – all in one place. The apps also provide Hims & Hers Members with access to curated content, direct messaging to their care team, as well as ongoing access to medical experts, helping members to get the most from their treatment.

Through the Hims and Hers apps, users can:

  • Start guided programs with videos developed with input from our expert medical advisors. From topics related to reducing anxiety to resolving hormonal acne, we believe Programs are an innovative new form factor that will help make superior medical expertise more readily available.
  • Manage all the details of your treatment or subscriptions in one place and conveniently access virtual care.
  • Get up-to-date shipment tracking each month with convenient notifications all the way to your door.
  • Within the Care section of the app, Hims & Hers Members will have around the clock access to highly trained coordinators to help you navigate the ecosystem, coordinate with your virtual care team, or get questions answered about your treatment.
  • Submit your burning questions confidentially and get real answers to frequently asked questions from licensed medical professionals.
  • Get access to new products and everyday favorites from Hims & Hers with recommendations curated just for you.

To learn more about Hims & Hers’ holistic, supportive, and proactive vision for personalized health and wellness, and to learn more about the app, please visit: http://app.forhims.com, http://app.forhers.com, or install the Hims app on Android or iOS and the Hers app on Android or iOS.

About Hims & Hers Health, Inc.

Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and wellness needs. Its digital platform enables access to treatments for a broad range of conditions, including those related to sexual health, hair loss, dermatology, mental health, and primary care. Hims & Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Prescriptions are fulfilled online through licensed pharmacies on a subscription basis, making accessing treatments simple, affordable, and straightforward. Through the Hims & Hers mobile apps, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Hims & Hers products can also be found in tens of thousands of top retail locations in the United States. Launched in November 2017, Hims & Hers serves the entire United States and select locations in the United Kingdom. The company is publicly traded on the New York Stock Exchange. For more information about Hims & Hers, please visit forhims.com and forhers.com.

_________________________

1 Engagement is defined as daily active users divided by monthly active users; data as of the end of Q2 2022.

Contacts

Investor Relations
Bill Newby
Investors@forhims.com

Media Relations
Press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Versions

Contacts

Investor Relations
Bill Newby
Investors@forhims.com

Media Relations
Press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continuing its international expansion efforts. Personalized treatment plans are available starting at $149 CAD/month, making...

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised treatment plans are available starting at $149/month CAD. GLP-1 treatments have transformed obesity and metabolic health, with...

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced of...
Back to Newsroom